MedPath

Aneuploidy Rate and Stimulation Protocol: Recombinant Follicle Stimulating Hormone (FSH) Versus Human FSH

Not Applicable
Terminated
Conditions
Aneuploidy Rate
Interventions
Procedure: Stimulation with human FSH
Procedure: Stimulation with recombinant FSH
Registration Number
NCT01164943
Lead Sponsor
IVI Madrid
Brief Summary

Several stimulation protocols have been used in in vitro fertilization (IVF) in a cycle of egg donation; recombinant FSH and human FSH are included. The effect of each kind of hormone on aneuploidy rate it is unknown. If there was an increase on aneuploidy rate of one of these stimulation protocols, there will be a negative effect on the successful rates in the egg donation cycles. The aim of this study is to observe if there is a different in aneuploidy rate and morphological oocyte parameters between different stimulation protocols.

Detailed Description

Not available

Recruitment & Eligibility

Status
TERMINATED
Sex
All
Target Recruitment
80
Inclusion Criteria
  • Egg donation cycles with more than 8MII in oocyte retrieval day
Exclusion Criteria
  • Male factor
  • Uterine malformations
  • genetic alterations

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Human FSHStimulation with human FSH-
Recombinant FSHStimulation with recombinant FSH-
Primary Outcome Measures
NameTimeMethod
Aneuploidy Rate2011 January

Analysis of all nuclei fixed

Secondary Outcome Measures
NameTimeMethod
Outcome rates (implantation, pregnancy and miscarriage rate)2011 April

Time requierd to know all the implantation, pregnancy and miscarriage rate

Oocyte morphology2011 january

Analysis of all oocytes

Trial Locations

Locations (1)

Insituto Valenciano de Infertilida, Spain, Madrid

🇪🇸

Madrid, Spain

© Copyright 2025. All Rights Reserved by MedPath